SAN DIEGO--(BUSINESS WIRE)--Nov. 5, 2019--
Gossamer Bio, Inc.(Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will report its third quarter 2019 financial results on Tuesday, November 12, 2019.
In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 4:30 p.m. ET on Tuesday, November 12, 2019 to discuss the Company’s financial results and provide a corporate update.
The live audio webcast may be accessed through the “Events and Presentations” page in the “Investors” section of the Company's website at https://ir.gossamerbio.com. Alternatively, the conference call may be accessed through the following:
Conference ID: 1981058
Domestic Dial-in Number: (866) 221-1654
International Dial-in Number: (470) 495-9466
Live Webcast: https://edge.media-server.com/mmc/p/f6gvpkxu
A replay of the audio webcast will be available for 30 days on the Investors section of the Company's website, www.gossamerbio.com.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191105005406/en/
Source: Gossamer Bio, Inc.
For Investors and Media: